TURTLE CAMERON (Chief Executive Officer) sold 2.3% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $739.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/3/2026ACC: 0001758363-26-000007
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$739.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−12.34K
Price / share
$49.20
Trade value
$607.32K
% of position
1.9%
4/1/2026
642.54K→630.20K
Common Stock
Direct
Shares
−2.66K
Price / share
$49.92
Trade value
$132.59K
% of position
0.4%
4/1/2026
630.20K→627.54K
Total
Net shares
−15K
Net value
-$739.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | S · Sale | −12.34K | $49.20 | $607.32K | 1.9% | 642.54K | 630.20K |
| Common Stock Direct | 4/1/2026 | S · Sale | −2.66K | $49.92 | $132.59K | 0.4% | 630.20K | 627.54K |
| Total | −15K | -$739.91K | ||||||
Derivative Transactions0
No derivative transactions reported